Peer Review History
Original SubmissionSeptember 3, 2021 |
---|
PONE-D-21-28194Physiological stress in response to multitasking and work interruptions: Study protocolPLOS ONE Dear Authors, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by 06.11.2021. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Eva M J Peters, M.D. Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For more information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. In your revised cover letter, please address the following prompts: a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. We will update your Data Availability statement on your behalf to reflect the information you provide. 3. Thank you for stating the following in the Funding Section of your manuscript: “This study is part of the research project "Identifikation biomedizinischer und gesundheitlicher Wirkweisen von positiven und negativen Auswirkungen von digitalem Stress und dessen Bewältigung“ [Identification of biomedical and health effects of positive and negative effects of digital stress and coping with it] which is part of the Bavarian Research Association on Healthy Use of Digital Technologies and Media (ForDigitHealth), funded by the Bavarian Ministry of Science and Arts. Linda Becker has been partly funded by the Emerging Talents Initiative of the Friedrich-Alexander University Erlangen-Nürnberg. Matthias Weigl and Dennis Nowak have been partly funded by the Munich Centre for Health Sciences (MC-Health). We acknowledge support by Deutsche Forschungsgemeinschaft and Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) within the funding program Open Access Publishing. The funders had and will not have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.” We note that you have provided additional information within the Funding Section. Please note that funding information should not appear in other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: “This study is part of the research project "Identifikation biomedizinischer und gesundheitlicher Wirkweisen von positiven und negativen Auswirkungen von digitalem Stress und dessen Bewältigung“ [Identification of biomedical and health effects of positive and negative effects of digital stress and coping with it] which is part of the Bavarian Research Association on Healthy Use of Digital Technologies and Media (ForDigitHealth), funded by the Bavarian Ministry of Science and Arts. Linda Becker has been partly funded by the Emerging Talents Initiative of the Friedrich-Alexander University Erlangen-Nürnberg. Matthias Weigl and Dennis Nowak have been partly funded by the Munich Centre for Health Sciences (MC-Health). We acknowledge support by Deutsche Forschungsgemeinschaft and Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) within the funding program Open Access Publishing. The funders had and will not have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.” Please include your amended statements within your cover letter; we will change the online submission form on your behalf. 4. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. Additional Editor Comments: Dear Authors, your manuscript has been reviewed favourably. Please answer all reviewers comments and resubmit. On behalve of PLOS One, yours, Eva Peters [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Does the manuscript provide a valid rationale for the proposed study, with clearly identified and justified research questions? The research question outlined is expected to address a valid academic problem or topic and contribute to the base of knowledge in the field. Reviewer #1: Yes Reviewer #2: Yes ********** 2. Is the protocol technically sound and planned in a manner that will lead to a meaningful outcome and allow testing the stated hypotheses? The manuscript should describe the methods in sufficient detail to prevent undisclosed flexibility in the experimental procedure or analysis pipeline, including sufficient outcome-neutral conditions (e.g. necessary controls, absence of floor or ceiling effects) to test the proposed hypotheses and a statistical power analysis where applicable. As there may be aspects of the methodology and analysis which can only be refined once the work is undertaken, authors should outline potential assumptions and explicitly describe what aspects of the proposed analyses, if any, are exploratory. Reviewer #1: Yes Reviewer #2: Yes ********** 3. Is the methodology feasible and described in sufficient detail to allow the work to be replicable? Descriptions of methods and materials in the protocol should be reported in sufficient detail for another researcher to reproduce all experiments and analyses. The protocol should describe the appropriate controls, sample size calculations, and replication needed to ensure that the data are robust and reproducible. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors described where all data underlying the findings will be made available when the study is complete? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception, at the time of publication. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: No ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above and, if applicable, provide comments about issues authors must address before this protocol can be accepted for publication. You may also include additional comments for the author, including concerns about research or publication ethics. You may also provide optional suggestions and comments to authors that they might find helpful in planning their study. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: In their manuscript, Becker et al. present a study protocol to investigate stress-reactivity inducing effects of dual- and multitasking as well as work interruptions by means of a standardized laboratory paradigm. The paradigm comprises 4 experimental conditions (digital interruptions, dual tasking with digital parallel task, dual tasking with non-digital task, and multi-tasking) and 2 control conditions (passive digital control and single digital task). The primary task is a computerized continuous-performance task; the digital secondary task comprises digitally presented items from an intelligence test with five answer possibilities; the non-digital secondary task consists of a verbal fluency task in the presence of a human experimenter; and the multitasking condition comprises all three tasks at the same time. Physiological reactivity testing includes assessment of SAM and HPA axis parameter reactivity before and up to 90 min after stress cessation, as well as immune measures, on a state-of-the-art level. The repeated measurement of relevant psychological state measures complements the physiological assessment and allows for psychological reactivity testing. Moreover, assessment of relevant trait measures allows to identify potential psychological correlates of physiological reactivity. The presented paradigm aims at closing a gap by extending the range of standardized laboratory stress induction protocols in order to specifically investigate multitasking and work interruptions as supposed stress-inducing elements of a today´s digitalized working environment. The presented paradigm and the proposed evaluation study are timely, highly innovative, important, and methodologically sound. I did enjoy reading this well-written manuscript. I have some minor comments. Introduction: - I did miss a part where the authors explain the term digital stress. In line 55, the authors jump to multitasking and work interruptions as forms of stressors due to increased digitalization, but the term digital stress had not been introduced before. A prior definition/explanation/clarification of the term digital stress would be helpful for the reader. - I would appreciate more careful wordings: o Line 53: I totally agree that stress is an important factor influencing human health, but it is a bit much to state that it is one of the most important factors. o “Most important” e.g. in lines 23, 53, 56 – maybe a more balanced wording? o Line 83: I agree that inflammatory processes definitely play a role in mediating negative effects of stress on health, but data do not justify that inflammation is the one and only central mechanism for all existing negative effects of stress on health - Line 90: only situations perceived as threatening? Or threatening and challenging as proposed by Lazarus in his transactional model of stress and shown in studies using the primary appraisal secondary appraisal (PASA) scale? Please also add references. - Line 95: reference 36 has been submitted but not yet published – this should be pointed out more clearly Objectives/Summary: - Line 106 ff: In how far does “acute and chronic psychosocial stress” differ from “multitasking and work interruptions”? This is a bit confusing as there seems some overlap, especially since two of the six presented stress conditions comprise the experimenter as psychosocial stress element. What exactly is the difference - do you refer to non-digital acute stress tests comprising single tasks or consecutive single tasks as “acute and chronic psychosocial stress”? Please clarify and provide a clear conceptual differentiation between previous stress research and the present study. - 445 ff: Similarly: in how far does “mental stress” differ from “digital stress”? It seems that mental stress includes digital stress as a sub form. Please clarify or correct. - Line 115: dual and multitasking what? Conditions? - Line 123: the physiological stress response to what? Methods: - There is some confusion with figure numbers; line 132 and 167 “Fig. 1” refers to Fig. 2; please check throughout the manuscript - Line 191 ff: o inconsistency – sometimes “condition”, sometimes “group” (l.199) o There is some confusion between text and figure: “condition 2” (line 197) refers to conditions 3 in the figure; and “group 3” (line 199) refers to condition 4 in the figure. Line 325 “Fig. 3” refers to Fig 1. Please check and correct. AW: [ext] AG, aktueller Stand - 215: please explicitly add (in brackets?) if this condition refers to condition 1 in the figure - Please clarify: non-digital secondary task: how is the VFT instruction given - a written instruction? A verbal instruction provided by the experimenter? - Please clarify: digital interruptions: does the primary task stop or does it continue (where – in the background?) when the interruption appears on the same screen? - Line 276/277: what are “items from 64”? Please clarify. - Why is depression assessed twice – CES-D and STADI-T? - 353: typo: plural – triplicateS - Randomization/group composition: The authors are experienced when it comes to effects of menstrual cycle phase and hormonal contraceptives on physiological stress reactivity. Please explain how you plan to rule out differential effects of female participants´ follicular and luteal phases of the menstrual cycle on (cortisol) stress reactivity and how to balance group compositions in terms of sex, use of hormonal contraceptives, and menstrual cycle phases. Reviewer #2: Thank you for giving me the opportunity to review the study protocol regarding the study „Physiological stress in response to multitasking and work interruptions“. The study planned by Linda Becker and coworkers is of interest to the readership of PLOS in my opinion as it deals with a topic that affects many persons during digitalization, namely being confronted with many tasks at the computer at the same time. In the planned study the effects of single tasking, dual tasking and multiple tasking on physiological parameters will be assessed. I think the study proticol needs clarification in some points though. Here are my concerns: 1. Why do you assess IL-6 as this is not a typical stress marker and also you very clear state in the theoretical background that you expect stress effects on the immune systems with delay. I would suggest to measure IL-6, but rather not directly after the tasks. 2. Page 5, line 80: Please explain what maladaptibe stress response patterns are in your opinion. 3. Page 5, line 84: Please also give some examples on the relationship between stress and dermatological conditions as the relationship is well understood in this field. 4. Page 6, line 123: In case the physiological stress response ist associated with these person characteristics, they need to be considered as covariates! Please add! 5. Page 7, line 134: why do you use such an age restriction? 6. Page 7, line 135: How do you operationalize psychological disorders (ever during life or at the current moment?) 7. Page 7, line 136: Please consider to stratify groups for usage of oral contraceptives. I would prefer to do this instead of just statistically controlling for this factor. 8. Page 7, line 137: Why is being an employee of the University Erlangen-Nürnberg an exclusion criterion? I suggest to omit or explain further why this is necessary. 9. Has the study protocol been registered at DRKS? If not please do so. 10. Page 8, line 161: What is the content of the non-stressful video. How do you guarantee that the video does not induce relaxation? Would that be a problem? Please think about this and add to the discussion section. 11. Page 9, line 171: Please already explain at this point: Who will be involved in randomization? Are subjects blinded? If yes, what do they think the intention of the study is? 12. Page 9, line 178: please explain this abbreviation 13. Page 10, line 194: Is intelligence (IQ) used as covariate? Intelligent persons might not get frustrated so fast which can have an effect on the stress parameters. Please consider! 14. Page 11, line 225: IL-6: See above, as stated in the Theoretical background you do not really seem to expect short-term effects on IL-6 or do you? Please, be specific. Do you expect effects after 24 hours or also immediate effects? 15. Page 12, line 257: I suggest to come up with a more detailed figure showing the timeline and in which you illustrate when each variable will be assessed using different symbols for the different variables. Figure 1 is not quite understandable at one glance. 16. Page 13, line 264 and the following: what will you do with all these variables? Do you plan to use them as control variables? Are these dependent variables? If yes, which correction procedure (adjustment) will you use? 17. Page 17: What is your main heart parameter? It seems that you will exploratively look at everything regarding the heart rate variability. Please, explicitely state at this point whether you will correct for multiple testing or not. 18. It seems a bit odd to have a results section in study protocol, thus of a study which is still ongoing or has not even started yet. Please, omit this heading and include the necessary information of this section somewhere else (Methods Section or Theoretical background). 19. Has data collection started already? 20. Is it planned to conduct inbetween analyses? 21. Please add a data management plan. Where will the data be stored, who will have access, will the data be made available to other researchers or in data repositories? If not, please give an explanation. 22. What is the clinical relevance of the study? Please add to the discussion session. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
Revision 1 |
Physiological stress in response to multitasking and work interruptions: Study protocol PONE-D-21-28194R1 Dear Dr. Becker, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Eva M J Peters, M.D. Academic Editor PLOS ONE Additional Editor Comments (optional): We are happy to accept your revised manuscript. Please attend to the last concerns raised by the reviewers. Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Does the manuscript provide a valid rationale for the proposed study, with clearly identified and justified research questions? The research question outlined is expected to address a valid academic problem or topic and contribute to the base of knowledge in the field. Reviewer #1: Yes Reviewer #2: Yes ********** 2. Is the protocol technically sound and planned in a manner that will lead to a meaningful outcome and allow testing the stated hypotheses? The manuscript should describe the methods in sufficient detail to prevent undisclosed flexibility in the experimental procedure or analysis pipeline, including sufficient outcome-neutral conditions (e.g. necessary controls, absence of floor or ceiling effects) to test the proposed hypotheses and a statistical power analysis where applicable. As there may be aspects of the methodology and analysis which can only be refined once the work is undertaken, authors should outline potential assumptions and explicitly describe what aspects of the proposed analyses, if any, are exploratory. Reviewer #1: Yes Reviewer #2: Yes ********** 3. Is the methodology feasible and described in sufficient detail to allow the work to be replicable? Descriptions of methods and materials in the protocol should be reported in sufficient detail for another researcher to reproduce all experiments and analyses. The protocol should describe the appropriate controls, sample size calculations, and replication needed to ensure that the data are robust and reproducible. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors described where all data underlying the findings will be made available when the study is complete? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception, at the time of publication. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above and, if applicable, provide comments about issues authors must address before this protocol can be accepted for publication. You may also include additional comments for the author, including concerns about research or publication ethics. You may also provide optional suggestions and comments to authors that they might find helpful in planning their study. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Congratulations to the authors for this very nice revision. My comments have been fully addressed. I have two last very minor comments: 1. Line 140: One bracket is missing after “…(so-called polychronicity; 57)) 2. Line 315: just listing a number (“87”) without brackets and thus a clear indication that it refers to a literature reference is irritating – please clarify by e.g. adding the author “… has been developed analogously based on the items by Koch (87) for...”. I recommend to accept the manuscript for publication. Reviewer #2: The study protocol has been improved according to my suggestions and I am fine with the study protocol in its current form. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No |
Formally Accepted |
PONE-D-21-28194R1 Physiological stress in response to multitasking and work interruptions: Study protocol Dear Dr. Becker: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Prof. Dr. Eva M J Peters Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .